XML 53 R72.htm IDEA: XBRL DOCUMENT v2.4.0.8
17. Parent Company Financial Statements (Unaudited) (Details) (USD $)
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Parent Company Financial Statements
Dec. 31, 2012
Parent Company Financial Statements
Dec. 31, 2010
Parent Company Financial Statements
Current assets:            
Cash and cash equivalents       $ 13,718 $ 0 $ 17,631
Intercompany receivables       27,627,159 20,802,877 0
Prepaid expenses 583,891 264,243        
Total current assets 12,706,908 6,845,449   27,640,877 20,802,877 23,458
Investments in Subsidiaries, net of advances            
Investment in Aemetis International, Inc.       2,678,525 3,060,684 9,831,430
Investment in Aemetis Americas, Inc       0 116,144 259,473
Total investments in Subsidiaries, net of advances       2,678,525 3,176,828 10,090,903
Other assets 2,923,011 3,365,244   23,095 23,095 23,096
Total Assets 97,141,892 96,872,159   30,342,497 24,002,800 10,139,650
Liabilities & stockholders' deficit            
Accounts payable 9,365,585 15,070,106   3,397,294 4,037,137 3,056,268
Outstanding checks in excess of cash       0 25,773 0
Mandatorily redeemable Series B convertibe preferred       2,539,528 2,437,649 2,221,872
Secured notes, net of discount for issuance cost 5,857,104 5,756,752        
Other current liabilities 6,245,745 5,803,857   1,677,835 2,174,608 1,714,229
Total current liabilities 36,116,546 57,835,203   7,614,657 8,675,167 8,126,086
Subsidiary obligation in excess of investment            
Investment in AE Advanced Fuels, Inc.       31,324,660 8,400,675 2,699,296
Investment in Aemetis Americas, Inc       246,676 0 0
Investment in Aemetis Biofuels, Inc.       2,741,279 2,624,575 2,488,735
Investment in Aemetis Technologies, Inc.       833,318 438,375 0
Investment in Biofuels Marketing, Inc.       349,056 349,056 360,185
Total subsidiary obligation in excess of investment       35,494,989 11,812,681 5,548,216
Total long term liabilities 73,792,495 35,522,004   35,494,989 11,812,681 11,463,272
Stockholders' equity/(deficit)            
Series B Preferred convertible stock 2,401 3,098   2,401 3,098 3,165
Common stock 199,737 180,281   199,737 180,281 90,342
Additional paid-in capital 84,192,552 75,457,760   84,192,552 75,457,760 38,557,376
Accumulated deficit (94,245,503) (69,808,294)   (94,245,503) (69,808,294) (47,229,670)
Accumulated other comprehensive loss (2,916,336) (2,317,893)   (2,916,336) (2,317,893) (870,921)
Total stockholders' equity(deficit) (12,767,149) 3,514,952 (22,203,082) (12,767,149) 3,514,952 (9,449,708)
Total liabilities & stockholders' equity (deficit) $ 97,141,892 $ 96,872,159   $ 30,342,497 $ 24,002,800 $ 10,139,650